Erythropoiesis stimulating agents will bear stricter labeling.
Erythropoiesis stimulating agents (ESAs) will bear stricter labeling and will require the distribution of a Medication Guide, following new requirements set down by the Food & Drug Administration. Among the changes are the following:
To see more Daily News articles, click here.
To go to the Drug Topics homepage, clickhere.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.